PPT-Reversing Course: Managing Anticoagulation and Antiplatelet Bleeding

Paul P Dobesh PharmD FCCP BCPS BCCP Professor of Pharmacy Practice and Science University of Nebraska Medical Center College of Pharmacy Omaha Nebraska USA Disclosures Consultant for the follow entities. Andrew McDonald. Alberts Cellular Therapy. “All bleeding eventually stops”. n. Modified Virchow’s triad. BLEEDING. Blood flow. Size. BP. Vessel wall. Endothelial activation. Collagen disorders. Thomas Savides, M.D.. Professor of Clinical Medicine. University of California, San Diego. Disclosures. None. Learning Objectives. Accurately assess the risk of bleeding in patients on anticoagulants and antiplatelet agents before endoscopic procedures. Antiplatelet Guidelines. . ANTIPLATELET THERAPY IN PATIENTS WITH CHRONIC KIDNEY DISEASE. Working. Group: . Neesh. . Pannu. , MD, SM, FRCP; Alan D. Bell, MD, CCFP. Interpret the Canadian Cardiovascular Society Guideline recommendations regarding the use antiplatelet . Stacey Graven, ACNP. Vascular Surgery, Springfield Clinic. Springfield, Illinois. VTE. In September 2008, Surgeon General issued a “Call to Action to Prevent Deep Venous Thrombosis and Pulmonary Embolis. Minilecture. Objectives. Indications for Antiplatelet Therapy in patients with CAD and ACS. Antiplatelet Therapy in the role of primary and secondary prevention of . c. ardiovascular events. CAD & the Vulnerable Plaque. . . Feb 08/2014. Hanadi. . Alhozali,MBBS,ABIM,FRCPC. Assistant professor consultant internal medicine and Nephrology KAUH/Jeddah. Glomerular- based disease and Renal disease in pregnancy. Objectives. Minilecture. Objectives. Indications for Antiplatelet Therapy in patients with CAD and ACS. Antiplatelet Therapy in the role of primary and secondary prevention of . c. ardiovascular events. CAD & the Vulnerable Plaque. Kevin Pham. May 2014. Objective. T o review the management of acute pulmonary embolism.. Case. A 48-year-old woman is brought to the emergency room complaining of a sudden onset of . dyspnea. . She reports she was standing in the kitchen making dinner, when she suddenly felt as if she could not get enough air, her heart started racing, and she became lightheaded and felt as if she would faint. . Introduction/Overview . VKA-Associated Bleeding: . Results From the RADOA Registry . Reversal Agents for VKA-Associated Anticoagulation. Management of Urgent Anticoagulation Reversal: . 4F-PCC vs FFP. Fibrillation. Michelle Tsukamoto . DSR 2 May 9, 2018. PGY 2. 1. Objectives. Discuss which patients with . atrial. fibrillation should be . anticoagulated. for CVA prevention. Learn about different oral anticoagulation options . Kevin Pham. May 2014. Objective. T o review the management of acute pulmonary embolism.. Case. A 48-year-old woman is brought to the emergency room complaining of a sudden onset of . dyspnea. . She reports she was standing in the kitchen making dinner, when she suddenly felt as if she could not get enough air, her heart started racing, and she became lightheaded and felt as if she would faint. . Management of Anticoagulants & Antiplatelet Agents Pre and Post Endoscopy Thomas Savides, M.D. Professor of Clinical Medicine University of California, San Diego Disclosures None Learning Objectives Anticoagulant therapy. (n = . 124). CADISS. P. rimary outcome. : . Ipsilateral . stroke or all-cause mortality . for antiplatelet vs. anticoagulation: 2. % . vs. 1%; p . = . 0.63. Any stroke: 2% vs. 1%, . OHHI Cardiology Group. Antiplatelet and Anticoagulation Therapy – What You Need to Know. Objectives. Utilize current practice guidelines for the management of antiplatelet therapy in CAD patients..